SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Hanna Bielarczyk, Agnieszka Jankowska-Kulawy, Corinna Höfling, Anna Ronowska, Sylwia Gul-Hinc, Steffen Roßner, Reinhard Schliebs, Tadeusz Pawelczyk, Andrzej Szutowicz, AβPP-Transgenic 2576 Mice Mimic Cell Type-Specific Aspects of Acetyl-CoA-Linked Metabolic Deficits in Alzheimer’s Disease, Journal of Alzheimer's Disease, 2015, 48, 4, 1083

    CrossRef

  2. 2
    Joey L. Methot, Christian Fischer, Chaomin Li, Alexey Rivkin, Sean P. Ahearn, William Colby Brown, Sam Kattar, Elizabeth Kelley, Dawn M. Mampreian, Adam Schell, Andrew Rosenau, Hua Zhou, Richard Ball, Sujal V. Deshmukh, Valentina V. Jeliazkova-Mecheva, Damaris Diaz, Lily Y. Moy, Candia M. Kenific, Chris Moxham, Sanjiv Shah, Hugh Nuthall, Alexander A. Szewczak, Armetta Hill, Bethany Hughes, Nadya Smotrov, Benito Munoz, Thomas A. Miller, Mark S. Shearman, Potent benzoazepinone γ-secretase modulators with improved bioavailability, Bioorganic & Medicinal Chemistry Letters, 2015, 25, 17, 3495

    CrossRef

  3. 3
    Jeremy H. Toyn, Lorin A. Thompson, Kimberley A. Lentz, Jere E. Meredith, Catherine R. Burton, Sethu Sankaranararyanan, Valerie Guss, Tracey Hall, Lawrence G. Iben, Carol M. Krause, Rudy Krause, Xu-Alan Lin, Maria Pierdomenico, Craig Polson, Alan S. Robertson, R. Rex Denton, James E. Grace, John Morrison, Joseph Raybon, Xiaoliang Zhuo, Kimberly Snow, Ramesh Padmanabha, Michele Agler, Kim Esposito, David Harden, Margaret Prack, Sam Varma, Victoria Wong, Yingjie Zhu, Tatyana Zvyaga, Samuel Gerritz, Lawrence R. Marcin, Mendi A. Higgins, Jianliang Shi, Cong Wei, Joseph L. Cantone, Dieter M. Drexler, John E. Macor, Richard E. Olson, Michael K. Ahlijanian, Charles F. Albright, Identification and Preclinical Pharmacology of theγ-Secretase Modulator BMS-869780, International Journal of Alzheimer's Disease, 2014, 2014, 1

    CrossRef

  4. 4
    Jeremy H Toyn, Michael K Ahlijanian, Interpreting Alzheimer’s disease clinical trials in light of the effects on amyloid-β, Alzheimer's Research & Therapy, 2014, 6, 2, 14

    CrossRef

  5. 5
    Pablo Galeano, Pamela V. Martino Adami, Sonia Do Carmo, Eduardo Blanco, Cecilia Rotondaro, Francisco Capani, Eduardo M. Castaño, A. Claudio Cuello, Laura Morelli, Longitudinal analysis of the behavioral phenotype in a novel transgenic rat model of early stages of Alzheimer's disease, Frontiers in Behavioral Neuroscience, 2014, 8,

    CrossRef

  6. 6
    Yasuyuki Mitani, Hiroki Akashiba, Kyoko Saita, Junko Yarimizu, Hiroshi Uchino, Mayuko Okabe, Makoto Asai, Shingo Yamasaki, Takashi Nozawa, Noritoshi Ishikawa, Yoshitsugu Shitaka, Keni Ni, Nobuya Matsuoka, Pharmacological characterization of the novel γ-secretase modulator AS2715348, a potential therapy for Alzheimer's disease, in rodents and nonhuman primates, Neuropharmacology, 2014, 79, 412

    CrossRef

  7. 7
    Christina J. Crump, Douglas S. Johnson, Yue-Ming Li, Development and Mechanism of γ-Secretase Modulators for Alzheimer’s Disease, Biochemistry, 2013, 52, 19, 3197

    CrossRef

  8. 8
    Martin Pettersson, Antonia F Stepan, Gregory W Kauffman, Douglas S Johnson, Novel γ-secretase modulators for the treatment of Alzheimer's disease: a review focusing on patents from 2010 to 2012, Expert Opinion on Therapeutic Patents, 2013, 23, 10, 1349

    CrossRef

  9. 9
    Mingming Zhang, Laura Hausmann, Weihong Song, Targeting nascent soluble Aβ42 for potential Alzheimer drug development, Journal of Neurochemistry, 2013, 125, 3